Test Price
2,800 AED✅ Home Collection Available
DCXR Gene Pentosuria Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines
تحليل جين DCXR لكشف البيلة الخماسية عبر التسلسل الجيني المتقدم (NGS) في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
Executive Summary
- Diagnostic Precision: 99.9% analytical sensitivity via ISO 15189-accredited NGS processing, exceeding DHA 2026 clinical validity benchmarks.
- Premium Logistics: Hospital-grade, cold‑chain home phlebotomy (8 AM‑11 PM) by DHA‑licensed nurses – no clinic visit required.
- Post‑Test Clinical Guidance: Telephonic interpretation session with a clinical geneticist, translating raw NGS data into actionable health insights.
- Insurance & Billing: Instant direct‑billing verification via WhatsApp at +971 54 548 8731.
يضمن هذا التحليل أعلى مستويات الدقة والامتثال للقوانين الصحية في دولة الإمارات العربية المتحدة، مع حماية كاملة لخصوصية البيانات الجينية.
Overview
The DCXR Gene Pentosuria NGS test detects pathogenic variants in the DCXR gene, confirming a diagnosis of essential pentosuria – a benign but under‑recognised metabolic anomaly. In the UAE, this ISO‑backed analysis empowers individuals, general physicians, and researchers with definitive genetic evidence for personalised carbohydrate metabolism management.
يكشف هذا التحليل الطفرات المسببة للمرض في جين DCXR لتأكيد الإصابة بالبيلة الخماسية الأساسية، وهو اضطراب استقلابي حميد غالباً ما يُهمل تشخيصه. يُتيح التحليل للمواطنين والمقيمين في الإمارات معرفة دقيقة بحالتهم الجينية لإدارة صحية مخصصة.
| Feature | Our DCXR NGS Test | Closest Alternative (PCR‑based) |
|---|---|---|
| Methodology | Next‑Generation Sequencing (Illumina NovaSeq) | Targeted PCR + Sanger confirmation |
| Variant Coverage | Full gene (>95% of coding regions, CNV detection) | Pre‑defined hotspot exons only |
| Turnaround Time | 15‑18 business days (with statutory UAE quality review) | 7‑10 business days (limited scope) |
| Price (AED) | 2800 | 1800‑2200 |
Pre‑Test Requirements
- Provide a detailed clinical history of the patient (prior metabolic work‑up, symptom diary).
- Undergo a pre‑test genetic counselling session to draw a pedigree chart of family members affected with pentosuria.
- For minors (under 18), ensure a legally authorised representative (parent/guardian) provides signed consent as mandated by UAE CDS Law 2026.
Physician Insight & Safety Protocol
“As a physician with extensive experience in metabolic genetics, I view the DCXR NGS test as a precise tool that must always be interpreted alongside clinical context. A positive result confirms essential pentosuria, a benign condition that does not require aggressive intervention, while a negative result may necessitate exploration of other carbohydrate‑metabolism disorders. I urge every patient to discuss the implications with a qualified specialist before and after testing.”
— Dr. PRABHAKAR REDDY, DHA License: 61713011
⚠️ Medication Warning
Do not discontinue any prescribed medication or alter your carbohydrate intake based solely on this test result. Always consult your supervising physician before making therapeutic changes.
Patient Safety & Exclusion Criteria
Exclusion Criteria for Home Collection:
- Known severe bleeding diathesis (e.g., haemophilia) – requires hospital‑based venipuncture.
- Active febrile illness or acute infection that may technically compromise DNA extraction from whole blood.
- Inability to provide informed consent (mental incapacity without a legal guardian).
ER Red Flags – Seek Immediate Medical Attention:
- New‑onset symptoms of metabolic crisis: unexplained hypoglycaemia, vomiting, or lethargy – do not wait for test results.
- Severe allergic reaction (anaphylaxis) during or after sample collection.
- Sudden confusion or loss of consciousness in the patient.
Patient FAQ & Clinical Guidance
What is the DCXR gene pentosuria test and who should consider it in the UAE?
The DCXR gene pentosuria test is a next‑generation sequencing analysis that identifies genetic variants causing essential pentosuria, a benign hereditary disorder of carbohydrate metabolism. It is especially valuable for UAE residents with persistent urinary pentose excretion, family history of unexplained carbohydrate anomalies, or for pre‑conception genetic counselling, supported by DHA‑approved laboratories.
اختبار جين DCXR للبيلة الخماسية هو تحليل تسلسل جيني متقدم يكتشف الطفرات المسببة للبيلة الخماسية الأساسية، وهو اضطراب استقلابي وراثي حميد. يُوصى به للمقيمين في الإمارات الذين يعانون من إفراز بنتوز بول دائم، أو تاريخ عائلي لاضطرابات الكربوهيدرات، أو قبل الزواج للاستشارة الوراثية.
How accurate is the NGS methodology and what does the 3‑4 week turnaround mean for clinical decisions?
NGS achieves 99.9% analytical sensitivity for single nucleotide variants and small indels, making it the gold‑standard for detecting DCXR mutations. The 15‑18 business‑day turnaround under UAE statutory review ensures your report is cross‑validated by two clinical molecular geneticists, providing reliable data for definitive dietary and lifestyle recommendations.
توفر تقنية التسلسل الجيني المتقدم (NGS) حساسية تحليلية تصل إلى 99.9% في الكشف عن طفرات DCXR، وهي المعيار الذهبي للتحليل. وتضمن مدة التسليم التي تتراوح بين 15 و18 يوم عمل خضوع التقرير لمراجعة مزدوجة من قبل خبراء الوراثة الجزيئية في الإمارات.
Is this covered by UAE health insurance and how do I arrange home collection?
Direct billing verification is conveniently provided: simply WhatsApp your Emirates ID and insurance card to +971 54 548 8731 for instant confirmation of coverage. Once approved, a DHA‑licensed phlebotomist will visit your home/office (8 AM‑11 PM) – the service includes all transport media and cold‑chain logistics at no extra cost.
نقدم خدمة التحقق المباشر من تغطية التأمين عبر إرسال صورة الهوية الإماراتية وبطاقة التأمين إلى واتساب الرقم +971 54 548 8731. بعد التأكيد، يقوم ممرض مرخص من هيئة الصحة بدبي بزيارة منزلية في الإمارات مدعومة بنقل مبرد معقم.
UAE Regulatory & Legal Compliance
- Federal Decree‑Law No. 41 of 2024 (Art. 87): All genetic data is processed, stored, and anonymised strictly within the UAE, adhering to the highest standards of medical confidentiality.
- CDS Law 2026 (Minors): Minors require mandatory parental consent and a court‑approved genetic counselling pathway before sample submission.
- UAE PDPL (Federal Decree‑Law No. 45 of 2021): Your genomic data is never shared with third parties without explicit, time‑bound consent; rights to data rectification and erasure are fully maintained.
- ISO 9001:2015 Certification (Cert: INT/EGQ/2509DA/3139): End‑to‑end quality management – from sample accession to bioinformatics pipeline – is audited annually by an EU‑accredited body.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians